ITMI20061917A1 - USE OF GROWTH HORMONE SECRETAGOGUES TO BLOCK OR INHIBIT THE ACTIVITY OF THE RENINA-ANGIOTENSINA SYSTEM - Google Patents

USE OF GROWTH HORMONE SECRETAGOGUES TO BLOCK OR INHIBIT THE ACTIVITY OF THE RENINA-ANGIOTENSINA SYSTEM

Info

Publication number
ITMI20061917A1
ITMI20061917A1 ITMI20061917A ITMI20061917A1 IT MI20061917 A1 ITMI20061917 A1 IT MI20061917A1 IT MI20061917 A ITMI20061917 A IT MI20061917A IT MI20061917 A1 ITMI20061917 A1 IT MI20061917A1
Authority
IT
Italy
Prior art keywords
angiotensina
renina
inhibit
activity
block
Prior art date
Application number
Other languages
Italian (it)
Inventor
Elena Bresciani
Ilaria Bulgarelli
Vittorio Locatelli
Monica Ravelli
Laura Tamiazzo
Antonio Biagio Torsello
Original Assignee
Univ Milano Bicocca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Milano Bicocca filed Critical Univ Milano Bicocca
Priority to ITMI20061917 priority Critical patent/ITMI20061917A1/en
Priority to PCT/IB2007/002934 priority patent/WO2008041106A2/en
Priority to EP07825260A priority patent/EP2066338A2/en
Publication of ITMI20061917A1 publication Critical patent/ITMI20061917A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITMI20061917 2006-10-05 2006-10-05 USE OF GROWTH HORMONE SECRETAGOGUES TO BLOCK OR INHIBIT THE ACTIVITY OF THE RENINA-ANGIOTENSINA SYSTEM ITMI20061917A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI20061917 ITMI20061917A1 (en) 2006-10-05 2006-10-05 USE OF GROWTH HORMONE SECRETAGOGUES TO BLOCK OR INHIBIT THE ACTIVITY OF THE RENINA-ANGIOTENSINA SYSTEM
PCT/IB2007/002934 WO2008041106A2 (en) 2006-10-05 2007-10-04 Use of growth hormone secretagogues to block or inhibit the renin-angiotensin system
EP07825260A EP2066338A2 (en) 2006-10-05 2007-10-04 Use of growth hormone secretagogues to block or inhibit the renin-angiotensin system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20061917 ITMI20061917A1 (en) 2006-10-05 2006-10-05 USE OF GROWTH HORMONE SECRETAGOGUES TO BLOCK OR INHIBIT THE ACTIVITY OF THE RENINA-ANGIOTENSINA SYSTEM

Publications (1)

Publication Number Publication Date
ITMI20061917A1 true ITMI20061917A1 (en) 2008-04-06

Family

ID=39247150

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI20061917 ITMI20061917A1 (en) 2006-10-05 2006-10-05 USE OF GROWTH HORMONE SECRETAGOGUES TO BLOCK OR INHIBIT THE ACTIVITY OF THE RENINA-ANGIOTENSINA SYSTEM

Country Status (3)

Country Link
EP (1) EP2066338A2 (en)
IT (1) ITMI20061917A1 (en)
WO (1) WO2008041106A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114984223B (en) * 2022-05-31 2023-06-20 中国人民解放军陆军军医大学第二附属医院 Use of growth hormone secretagogue receptor antagonists for the preparation of inhalation anesthetic resuscitation formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005539091A (en) * 2002-08-23 2005-12-22 バラリゼーション−ラシェアシェイ ソサイテ エン コマンディテ Growth hormone releasing peptides in the treatment or prevention of atherosclerosis and hypercholesterolemia
WO2005039625A1 (en) * 2003-10-28 2005-05-06 Rheoscience A/S Growth hormone secretagogue receptor agonists

Also Published As

Publication number Publication date
WO2008041106A2 (en) 2008-04-10
EP2066338A2 (en) 2009-06-10
WO2008041106A3 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
BRPI0819582A2 (en) "liquid treatment system"
ME01032B (en) Forms of rifaximin and uses thereof
CL2013001654A1 (en) Compounds derived from 6-amino-2-phenylamino-1h-benzimidazol-5-carboxamide; pharmaceutical composition; and its use in the treatment and / or prevention of inflammatory diseases and / or associated conditions, in particular pain.
CL2007002017A1 (en) COMPOUNDS DERIVED FROM [4,5 '] - BIPIRIMIDINIL-6,4'-DIAMINE; PHARMACEUTICAL COMPOSITION; AND USE AS AN INHIBITOR OF THE ACTIVITY OF CINASA IN CANCER DE VEJIGA, CANCER CERVICAL AND MIELOMA MULTIPLE.
DK2066684T3 (en) 5'-Modified Bicyclic Nucleic Acid Analogs
BRPI0913488A2 (en) "filtration system"
HK1122723A1 (en) Intranasal administration of active agents to the central nervous system
BRPI0814529A2 (en) 2-3-DIHYDROBENZO [1,4] DIOXIN-2-ILMETIL DERIVATIVES AS ALFA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERAL AND CENTRAL NERVOUS SYSTEM DISEASES.
EP2207802A4 (en) Intranasal administration of active agents to the central nervous system
CL2007003472A1 (en) SMOKE SALT OF (ALFA S, BETA R) -6-BROMO-ALFA- [2- (DIMETILAMINO) ETIL] -2-METOXI-ALFA-1-NAFTALENIL-BETA-PHENYL-3-QUINOLINAETHANOL; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMPOSITION PREPARATION PROCESS; AND USE IN THE TREATMENT
SI2137141T1 (en) Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents
BRPI0809810A2 (en) "VIDEO MONITOR SYSTEM"
IL216967B (en) 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives and use thereof for the treatment of diseases
DK1855700T3 (en) Use of neuronal precursor cells to treat lesions of the central nervous system
IT1403312B1 (en) DRIVER ASSISTANCE SYSTEM AND PROCEDURE FOR DRIVER ASSISTANCE FOR THE AUTOMATIC DRIVER
BRPI0810475A2 (en) use of dimiracetam in the treatment of chronic pain
BRPI0817483A2 (en) use of sulfonyl substituted 2-sulfonylaminobenzoic acid n-phenylamides in the treatment of pain
HK1216993A1 (en) Rh-epo nasal formulations with low sialic acid concentration for the treatment of diseases of the central nervous system
BRPI0907282A2 (en) "locking system"
FR2927900B1 (en) PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ALPHA-AMINOACETALS
ITRM20060346A1 (en) COMPOSITIONS WITH ANTIGERMINATIVE ACTIVITY PROCESSES TO OBTAIN THOSE COMPOSITIONS AND THEIR USE
ITBO20050385A1 (en) SYSTEM FOR OPTIMIZING THE USE OF ADHERENCE DEVICES
ITMI20061917A1 (en) USE OF GROWTH HORMONE SECRETAGOGUES TO BLOCK OR INHIBIT THE ACTIVITY OF THE RENINA-ANGIOTENSINA SYSTEM
EA201171373A1 (en) METHODS AND COMPOSITIONS FOR FIGHTING ECTOPARASITES
ITNA20060119A1 (en) SYSTEM TO FACILITATE THE WINDSURF TEACHING